देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
DESMOPRESSIN ACETATE
FERRING INC
H01BA02
DESMOPRESSIN
150MCG
SPRAY
DESMOPRESSIN ACETATE 150MCG
NASAL
2.5ML
Prescription
PITUITARY
Active ingredient group (AIG) number: 0112050007; AHFS:
CANCELLED POST MARKET
2020-07-17
_ _ _Octostim_ _®_ _ Injection and Nasal Spray _ _Page 1 of 29 _ PRODUCT MONOGRAPH OCTOSTIM ® Desmopressin Acetate Injection (15 µg/mL) Nasal Spray (1.5 mg/mL) (Each metered dose delivers 150 µg/spray) USP Antihemorrhagic Ferring Inc. 200 Yorkland Blvd., Suite 500 North York, Ontario M2J 5C1 Date of Revision: April 12, 2018 Submission Control No: 212397 _ _ _Octostim_ _®_ _Injection_ _ _ _and Nasal Spray _ _Page 2 of 29 _ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..........................................................3 SUMMARY PRODUCT INFORMATION ........................................................................... 3 INDICATIONS AND CLINICAL USE ................................................................................. 3 CONTRAINDICATIONS ...................................................................................................... 4 WARNINGS AND PRECAUTIONS ..................................................................................... 5 ADVERSE REACTIONS ....................................................................................................... 9 DRUG INTERACTIONS ..................................................................................................... 10 DOSAGE AND ADMINISTRATION ................................................................................. 11 OVERDOSAGE ................................................................................................................... 12 ACTION AND CLINICAL PHARMACOLOGY ............................................................... 12 STORAGE AND STABILITY ............................................................................................. 16 SPECIAL HANDLING INSTRUCTIONS .......................................................................... 16 DOSAGE FORMS, COMPOSITION AND PACKAGING ................................................ 16 PART II: SCIENTIFIC INFORMATION ...............................................................................18 PHARMACEUTICAL INFORMAT पूरा दस्तावेज़ पढ़ें